Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Koninklijke Philips N.V.NYSE: PHG

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin widens to 14.0%

Operating margin was 14.0% in Q2 FY2026, up 4.8 pp from a year earlier. On a trailing-twelve-month basis it was 9.7%, up 3.6 pp year over year. Over 3 fiscal years it widened by 16.6 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 10 analysts of 14.2% for the fiscal year ending Dec 2026, up from 8.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
14.0%+7.8 pp QoQ
Last fiscal yearDec 2025
8.0%+5.0 pp YoY
LTMJun 2026
9.7%+3.6 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.8 pp+4.9 pp+0.2 pp
1 year+5.0 pp+6.2 pp+1.1 pp
3 years+16.6 pp+6.5 pp-10.1 pp
5 years+7.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.0%
Year-over-year change
+5.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How PHG compares with its peers on the latest reported figures

  • PHG's LTM Jun 2026 operating margin of 9.7% is the 9th highest of the 10 companies compared; the peer median is 15.2%.
  • Its year-over-year change of +3.6 pp is the 3rd highest of 10, against a peer median of +0.7 pp.
  • Over three fiscal years its change of +16.6 pp compares with a peer median of +4.3 pp.
PHG Competitors Peer median
Operating Margin for PHG and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202633.5% +0.7 pp+7.0 pp
IRMDIRadimed CorporationLTM Mar 202632.4% +2.3 pp+1.9 pp
BSXBoston Scientific CorporationLTM Jun 202621.5% +5.4 pp+5.4 pp
MDTMedtronic plcLTM Jul 202618.1% +0.2 pp+0.2 pp
ABTAbbott LaboratoriesLTM Sep 202615.2% -2.5 pp-1.0 pp
SNNSmith & Nephew plcFY202512.9% +1.6 pp+4.3 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202612.7% -1.1 pp-0.4 pp
LIVNLivaNova PLCLTM Sep 202611.5% -2.9 pp+21.9 pp
PHGKoninklijke Philips N.V.LTM Jun 20269.7% +3.6 pp+16.6 pp
NPCENeuroPace, Inc.LTM Mar 2026-16.8% +6.0 pp+73.3 pp
Peer median (excluding PHG) 15.2%+0.7 pp+4.3 pp

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.